NEW YORK, July 1 - Millennium Pharmaceuticals' chief technology officer, Mike Pavia, will be leaving the company at the end of the week.
Pavia, who spent five years with the company, will become entrepreneur-in-residence at Oxford Bioscience Partners, he said in a recent e-mail message. He also will remain a consultant to Millennium.
"It's time to go out and help incubate the next generation of technologies," Pavia said.
Allan Marchington, senior vice president of productivity, will take over Pavia's responsibilities.